Brazil will apply fourth dose of vaccines against Covid-19 for immunosuppressed people

Immunosuppressed people will be able to receive a fourth dose of the Covid-19 vaccine in Brazil, four months after the application of the third, the Ministry of Health announced on Monday.

The portfolio recommended in a note “a booster dose for all individuals immunosuppressed older than 18 years who have already received three doses previously (…) after four months “from the last.

The measure particularly concerns people with severe immunodeficiencies, such as HIV carriers The cancer patients undergoing chemotherapy.

The ministry also reported that it plans to reduce the interval between the second and third doses from five to four months for the general population.

The government also announced on Monday the donation of 10 million doses of vaccines to vulnerable countries, through the system Covax from World Health Organization (WHO).

The ministry assured that this donation “will not compromise the vaccination plan” of the population in the country.

Vaccination in Brazil has accelerated in recent months and, so far, more than two-thirds of the population has already received at least two doses of the immunizers.

But the immunization campaign got off to a late and chaotic start, amid attacks on vaccines by the far-right president, Jair Bolsonaro.

The head of state, who refuses to be vaccinated, has criticized in recent days the decision of the health regulator, Anvisa, to authorize the vaccination of children between 5 and 11 years old.

During his weekly presentation broadcast live by Facebook, Bolsonaro requested the publication of the names of the Anvisa members responsible for the authorization.

An association representing Anvisa employees denounced Bolsonaro’s “fascist methods”. The regulator asked the Federal Police to protect its personnel after having “received threats of violence.”

Covid-19 has caused more than 617,000 deaths in Brazil, the second most mourning country in the world in absolute numbers after the United States.



Reference-www.eleconomista.com.mx

Leave a Comment